MedPath

国药集团宜宾制药有限责任公司

Ownership
-
Established
1999-08-18
Employees
-
Market Cap
-
Website
www.guoyaoyb.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

135

NMPA:135

Drug Approvals

金刚藤口服液

Approval Number
国药准字Z20080455
Approval Date
Oct 23, 2024
NMPA

Eperisone Hydrochloride

Product Name
盐酸乙哌立松
Approval Number
国药准字H20031239
Approval Date
Apr 24, 2024
NMPA

Aniracetam

Product Name
茴拉西坦
Approval Number
国药准字H20063311
Approval Date
Apr 24, 2024
NMPA

nevirapine

Product Name
奈韦拉平
Approval Number
国药准字H20143247
Approval Date
Apr 24, 2024
NMPA

Berberine Hydrochloride

Product Name
盐酸小檗碱
Approval Number
国药准字H51022267
Approval Date
Apr 24, 2024
NMPA

Potassium Dehydroandrographolide Succinate

Product Name
穿琥宁
Approval Number
国药准字H51023317
Approval Date
Apr 24, 2024
NMPA

决明降脂胶囊

Approval Number
国药准字Z20090330
Approval Date
Aug 23, 2023
NMPA

八珍片

Approval Number
国药准字Z20080316
Approval Date
Jun 12, 2023
NMPA

脑心清胶囊

Approval Number
国药准字Z20080201
Approval Date
Jun 12, 2023
NMPA

Sodium Phosphates Oral Solution

Product Name
磷酸钠盐口服溶液
Approval Number
国药准字H20110131
Approval Date
Aug 26, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.